Transcatheter aortic valve implantation: a blueprint for evidence-based evaluation of technological innovation
- PMID: 36660805
- DOI: 10.1093/eurheartj/ehac635
Transcatheter aortic valve implantation: a blueprint for evidence-based evaluation of technological innovation
Conflict of interest statement
Conflict of interest: T.P. reports research grants to the institution from Biotronik, Boston Scientific, and Edwards Lifesciences; and speaker fees/consultancy from Biotronik, Boston Scientific, Medtronic, Abbott, and HighLife SAS. G.C.M.S. reports no conflicts of interest. S.W. reports research, travel, or educational grants to the institution from Abbott, Abiomed, Amgen, Astra Zeneca, Bayer, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cardinal Health, CardioValve, Corflow Therapeutics, CSL Behring, Daiichi Sankyo, Edwards Lifesciences, Guerbet, InfraRedx, Janssen-Cilag, Johnson & Johnson, Medicure, Medtronic, Merck Sharp & Dohm, Miracor Medical, Novartis, Novo Nordisk, Organon, OrPha Suisse, Pfizer, Polares, Regeneron, Sanofi-Aventis, Servier, Sinomed, Terumo, Vifor, and V-Wave; and serves as advisory board member and/or member of the steering/executive group of trials funded by Abbott, Abiomed, Amgen, Astra Zeneca, Bayer, Boston Scientific, Biotronik, Bristol Myers Squibb, Edwards Lifesciences, Janssen, MedAlliance, Medtronic, Novartis, Polares, Recardio, Sinomed, Terumo, V-Wave, and Xeltis with payments to the institution but no personal payments. He is also a member of the steering/executive committee group of several investigator-initiated trials that receive funding by industry without impact on his personal remuneration.
Comment on
-
Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials.Eur Heart J. 2023 Mar 7;44(10):836-852. doi: 10.1093/eurheartj/ehac642. Eur Heart J. 2023. PMID: 36660821
Similar articles
-
Rapid deployment aortic valve systems: The surgeons' alternative to Transcatheter Aortic Valve Implantation?J Thorac Cardiovasc Surg. 2017 Nov;154(5):1568-1569. doi: 10.1016/j.jtcvs.2017.07.012. J Thorac Cardiovasc Surg. 2017. PMID: 29042039 No abstract available.
-
The DEDICATE Trial: An independent all-comers trial of transcatheter aortic valve implantation vs. surgical aortic valve replacement in patients at low to intermediate operative risk is recruiting patients.Eur Heart J. 2019 Jan 21;40(4):331-333. doi: 10.1093/eurheartj/ehy851. Eur Heart J. 2019. PMID: 30668699 Review. No abstract available.
-
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement?: A Meta-Analysis of Randomized Controlled Trials.JACC Cardiovasc Interv. 2017 Sep 25;10(18):1899-1901. doi: 10.1016/j.jcin.2017.06.025. JACC Cardiovasc Interv. 2017. PMID: 28935083 No abstract available.
-
Transcatheter versus surgical aortic valve replacement: what does the latest evidence tell us?Eur J Cardiothorac Surg. 2019 Jul 1;56(1):7-9. doi: 10.1093/ejcts/ezz163. Eur J Cardiothorac Surg. 2019. PMID: 31131399 No abstract available.
-
A Case Study on Reviewing Specialist Services Commissioning in Wales: TAVI for Severe Aortic Stenosis.Appl Health Econ Health Policy. 2022 Jul;20(4):487-499. doi: 10.1007/s40258-021-00692-y. Epub 2022 Feb 25. Appl Health Econ Health Policy. 2022. PMID: 35211878 Free PMC article. Review.
Cited by
-
Colchicine in patients with aortic stenosis undergoing transcatheter aortic valve replacement: a double-blind randomized trial.Nat Commun. 2025 Jul 15;16(1):6501. doi: 10.1038/s41467-025-61916-6. Nat Commun. 2025. PMID: 40659682 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
